How suitable is intravenous tocilizumab for the treatment of Graves' ophthalmopathy?. (2nd November 2021)

Record Type:: Journal Article
Title:: How suitable is intravenous tocilizumab for the treatment of Graves' ophthalmopathy?. (2nd November 2021)
Main Title:: How suitable is intravenous tocilizumab for the treatment of Graves' ophthalmopathy?
Authors:: Mejía González, Maria Alejandra
Carbone, Javier
Abstract:
Is Part Of:: Expert review of clinical immunology. Volume 17:Number 11(2021)
Journal:: Expert review of clinical immunology
Issue:: Volume 17:Number 11(2021)
Issue Display:: Volume 17, Issue 11 (2021)
Year:: 2021
Volume:: 17
Issue:: 11
Issue Sort Value:: 2021-0017-0011-0000
Page Start:: 1151
Page End:: 1153
Publication Date:: 2021-11-02
Subjects:: Graves' ophthalmopathy -- therapy -- glucocorticoids -- tocilizumab -- immunotherapy
Clinical immunology -- Periodicals
616.079
Journal URLs:: http://www.tandfonline.com/toc/ierm20/current ↗
http://www.future-drugs.com/loi/eci ↗
http://informahealthcare.com ↗
DOI:: 10.1080/1744666X.2021.1997591 ↗
Languages:: English
ISSNs:: 1744-666X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002985
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 20106.xml